Tatva Chintan Pharma
Ticker > Company >

Tatva Chintan Pharma share price

Tatva Chintan Pharma Chem Ltd.

NSE: TATVA BSE: 543321 SECTOR: Chemicals  159k   470   84

825.00
+2.00 (0.24%)
BSE: 22 Nov 04:00 PM

Price Summary

Today's High

₹ 829.7

Today's Low

₹ 809.55

52 Week High

₹ 1647.95

52 Week Low

₹ 789.05

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 1929.84 Cr.

Enterprise Value

₹ 1907.14 Cr.

No. of Shares

2.34 Cr.

P/E

145.15

P/B

2.67

Face Value

₹ 10

Div. Yield

0.25 %

Book Value (TTM)

₹  308.43

CASH

₹ 36.97 Cr.

DEBT

₹ 14.27 Cr.

Promoter Holding

72.02 %

EPS (TTM)

₹  5.68

Sales Growth

-6.05%

ROE

4.77 %

ROCE

6.91%

Profit Growth

-27.47 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-6.05%
3 Year9.15%
5 Year13.29%

Profit Growth

1 Year-27.47%
3 Year-17.02%
5 Year7.77%

ROE%

1 Year4.77%
3 Year14.5%
5 Year23.34%

ROCE %

1 Year6.91%
3 Year13.4%
5 Year18.97%

Debt/Equity

0.0197

Price to Cash Flow

18.78

Interest Cover Ratio

7.3499

CFO/PAT (5 Yr. Avg.)

0.752829979137084

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 72.02 0.00
Jun 2024 72.02 0.00
Mar 2024 72.02 0.00
Dec 2023 72.02 0.00
Sep 2023 72.02 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 155.986 Cr.
  • Company is virtually debt free.
  • Company has a healthy liquidity position with current ratio of 3.1827.
  • The company has a high promoter holding of 72.02%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.55927837821784.

 Limitations

  • The company has shown a poor profit growth of -17.0173466633757% for the Past 3 years.
  • The company has shown a poor revenue growth of 9.15193466896298% for the Past 3 years.
  • The company is trading at a high PE of 145.15.
  • The company is trading at a high EV/EBITDA of 40.4605.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 92.57 86.07 93.93 93.81 80.96
Total Expenditure 71.83 73.76 79.73 86.11 76.36
Operating Profit 20.74 12.31 14.2 7.7 4.6
Other Income 0.76 1.21 4.53 1.42 0.81
Interest 3.01 0.38 0.22 0.31 0.17
Depreciation 6.78 6.58 6.23 6.66 6.81
Exceptional Items 0 0 0 0 0
Profit Before Tax 11.71 6.56 12.28 2.14 -1.58
Tax 3.5 1.91 4.03 0.63 -0.47
Profit After Tax 8.2 4.65 8.25 1.51 -1.11
Adjusted EPS (Rs) 3.51 1.99 3.53 0.64 -0.47

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 253.84 291.19 427.81 403.04 378.68
Total Expenditure 201.14 225.8 321.81 348.23 311.66
Operating Profit 52.7 65.39 106.01 54.82 67.01
Other Income 0.56 5.1 10.63 5.68 7.51
Interest 4.25 4.41 5.19 8.52 6.66
Depreciation 4.79 6.73 8.18 9.55 25.6
Exceptional Items 0 0 0 -3.59 0
Profit Before Tax 44.22 59.35 103.27 38.83 42.27
Tax 9.25 7.99 7.28 -1.63 12.92
Net Profit 34.96 51.36 95.99 40.47 29.35
Adjusted EPS (Rs.) 17.41 25.57 43.31 18.26 12.55

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 8.04 20.09 22.17 22.17 23.39
Total Reserves 106.41 141.85 446.71 482.62 702.49
Borrowings 38.71 26.76 13.11 4.23 0.64
Other N/C liabilities 4.89 4.06 -8.05 -15.26 -10.96
Current liabilities 87.26 127.08 193.55 246.58 94.56
Total Liabilities 245.31 319.83 667.49 740.34 810.11
Assets
Net Block 111.18 120.45 159.61 196.22 426.87
Capital WIP 4.89 9.81 51.49 230.74 72.93
Intangible WIP 0 0 0 0 3.61
Investments 0.67 0.67 0.67 0.67 0.67
Loans & Advances 0.17 0.3 2.09 2.66 4.26
Other N/C Assets 0 0 0.51 0.55 0.83
Current Assets 128.4 188.61 453.12 309.49 300.95
Total Assets 245.31 319.83 667.49 740.34 810.11
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 44.22 59.35 103.27 38.83 42.27
Adjustment 8.2 6.92 9.64 15.82 28.17
Changes in Assets & Liabilities -20.4 -37.55 -75.18 -23.18 40.58
Tax Paid -7.39 -9.82 -17.97 -7.74 -8.24
Operating Cash Flow 24.64 18.91 19.76 23.73 102.78
Investing Cash Flow -40.18 -20.61 -196.72 -101.13 -120.52
Financing Cash Flow 9.7 -4.72 235.01 37.82 30.54
Net Cash Flow -5.85 -6.42 58.05 -39.59 12.8

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 72.02 72.02 72.02 72.02 72.02
ajay mansukhlal patel 17.10 17.10 17.10 17.10 17.10
ajay mansukhlal patel (hu... 3.06 3.06 3.06 3.06 3.06
chintan n shah (huf) 1.91 1.91 1.91 1.91 1.91
chintan nitinkumar shah 20.94 20.94 20.94 20.94 20.94
darshana nitinkumar shah 0.17 0.17 0.17 0.17 0.17
kajalben shekharkumar som... 0.93 0.93 0.93 0.93 0.93
priti ajay patel 3.85 3.85 3.85 3.85 3.85
shekhar rasiklal somani 23.07 23.07 23.07 23.07 23.07
shital chintan shah 0.99 0.99 0.99 0.99 0.99
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 27.98 27.98 27.98 27.98 27.98
goldman sachs funds - gol... 1.89 2.06 2.30 2.40 2.54
icici prudential smallcap... 2.19 2.15 2.01 1.92 1.81
llp 0.01 0.09 0.01 0.02 0.03
nippon life india trustee... - 5.93 5.90 5.90 4.31
sbi magnum midcap fund 2.78 2.78 2.77 2.77 -
mirae asset aggressive hy... - 1.64 1.64 - -
abu dhabi investment auth... 1.23 - - - -
mirae asset hybrid - equi... 1.64 - - - -
nippon life india trustee... 6.21 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Tatva Chintan Pharma Chem informs about newspaper publication 26 Oct, 3:36 PM Tatva Chintan Pharma - Quaterly Results 25 Oct, 3:50 PM Tatva Chintan Pharma - Quaterly Results 25 Oct, 3:50 PM Tatva Chintan Pharma - Quaterly Results 25 Oct, 3:50 PM Tatva Chintan Pharma Chem submits board meeting intimation 16 Oct, 5:28 PM Tatva Chintan Pharma Chem informs about investors meeting 23 Sep, 2:52 PM Tatva Chintan Pharma Chem informs about newspaper advertisement 17 Aug, 10:33 AM Tatva Chintan Pharma - Quaterly Results 24 Jul, 3:39 PM Tatva Chintan Pharma - Quaterly Results 24 Jul, 3:39 PM Tatva Chintan Pharma - Quaterly Results 24 Jul, 3:39 PM Tatva Chintan Pharma Chem informs about board meeting 16 Jul, 12:03 PM Tatva Chintan Pharma Chem informs about analyst meet 22 Jun, 11:05 AM Tatva Chintan Pharma Chem submits analyst meet intimation 10 Jun, 4:37 PM Tatva Chintan Pharma Chem informs about earnings call transcript 7 May, 5:16 PM Tatva Chintan Pharma - Quaterly Results 3 May, 3:41 PM Tatva Chintan Pharma - Quaterly Results 3 May, 3:41 PM Tatva Chintan Pharma - Quaterly Results 3 May, 3:41 PM Tatva Chintan Pharma Chem submits analyst meet intimation 16 Mar, 11:59 AM Tatva Chintan Pharma Chem informs about update 27 Jan, 4:28 PM Tatva Chintan Pharma - Quaterly Results 20 Jan, 3:26 PM Tatva Chintan Pharma - Quaterly Results 20 Jan, 3:26 PM Tatva Chintan Pharma - Quaterly Results 20 Jan, 3:26 PM Tatva Chintan Pharma Chem informs about earnings call 17 Jan, 4:55 PM Tatva Chintan Pharma - Quaterly Results 2 Nov, 3:57 PM Tatva Chintan Pharma - Quaterly Results 2 Nov, 3:57 PM Tatva Chintan Pharma - Quaterly Results 2 Nov, 3:57 PM Tatva Chintan Pharma Chem informs about disclosure 8 Sep, 3:52 PM Tatva Chintan Pharma Chem informs about disclosure 7 Sep, 5:16 PM Tatva Chintan Pharma Chem informs about newspaper publication 5 Aug, 1:27 PM Tatva Chintan Pharma - Quaterly Results 4 Aug, 3:03 PM Tatva Chintan Pharma - Quaterly Results 4 Aug, 3:03 PM Tatva Chintan Pharma - Quaterly Results 4 Aug, 3:03 PM Tatva Chintan Pharma Chem informs about newspaper publication 6 May, 2:36 PM Tatva Chintan Pharma Chem informs about press release 5 May, 5:07 PM Tatva Chintan Pharma Chem board approves dividend 5 May, 4:45 PM Tatva Chintan Pharma - Quaterly Results 5 May, 3:49 PM Tatva Chintan Pharma - Quaterly Results 5 May, 3:49 PM Tatva Chintan Pharma - Quaterly Results 5 May, 3:49 PM Tatva Chintan Pharma Chem informs about disclosure 4 May, 4:34 PM Tatva Chintan Pharma Chem informs about certificate 12 Apr, 4:51 PM Tatva Chintan Pharma Chem starts commercial production of new facility at Dahej Manufacturing Plant 6 Apr, 2:38 PM Tatva Chintan Pharma Chem informs about analyst meet 25 Feb, 11:55 AM Tatva Chintan Pharma - Quaterly Results 24 Jan, 3:48 PM Tatva Chintan Pharma - Quaterly Results 24 Jan, 3:48 PM Tatva Chintan Pharma - Quaterly Results 24 Jan, 3:48 PM Tatva Chintan Pharma Chem informs about board meeting 13 Jan, 4:28 PM Tatva Chintan Pharma Chem informs about analyst meet 24 Nov, 10:56 AM Tatva Chintan Pharma Chem informs about analyst meet 14 Nov, 2:02 PM Tatva Chintan Pharma Chem informs about newspaper publication 5 Nov, 3:07 PM Tatva Chintan Pharma - Quaterly Results 4 Nov, 4:15 PM

Tatva Chintan Pharma Stock Price Analysis and Quick Research Report. Is Tatva Chintan Pharma an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Tatva Chintan Pharma stock price today is Rs 824.6. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Tatva Chintan Pharma . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Tatva Chintan Pharma has a PE ratio of 145.08410162573 which is high and comparatively overvalued .

  • Share Price: - The current share price of Tatva Chintan Pharma is Rs 824.6. One can use valuation calculators of ticker to know if Tatva Chintan Pharma share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Tatva Chintan Pharma has ROA of 3.7857 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Tatva Chintan Pharma has a Current ratio of 3.1827 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Tatva Chintan Pharma has a ROE of 4.7695 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Tatva Chintan Pharma has a Debt to Equity ratio of 0.0197 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Tatva Chintan Pharma has reported revenue growth of -6.0457 % which is poor in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Tatva Chintan Pharma for the current financial year is 17.6968762296099 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Tatva Chintan Pharma is Rs 2 and the yield is 0.2478 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Tatva Chintan Pharma is Rs 5.6836 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Tatva Chintan Pharma in Ticker for free. Also, one can get the intrinsic value of Tatva Chintan Pharma by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Tatva Chintan Pharma

Tatva Chintan Pharma Chem Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Tatva Chintan Pharma Chem Ltd., established in 1996, is a specialty chemical manufacturing company based in India. With a focus on manufacturing a wide range of chemical products, the company has built a strong reputation for delivering high-quality products to its customers across various industries. Tatva Chintan Pharma Chem is known for its commitment to research and innovation, continuously developing new products to cater to the evolving market demands.

Tatva Chintan Pharma Chem Ltd. - Share Price

Stay updated with the latest share price of Tatva Chintan Pharma Chem Ltd. on our website. As a long-term stock investor, it is crucial to keep track of the company's share price trends. By analyzing historic share price movements and understanding the factors influencing them, you can make informed decisions regarding your investment portfolio.

Tatva Chintan Pharma Chem Ltd. - Balance Sheet

Access the balance sheet of Tatva Chintan Pharma Chem Ltd. on our website. The balance sheet provides a snapshot of the company's financial position, including its assets, liabilities, and shareholders' equity. With the help of our pre-built screening tools, you can perform a comprehensive analysis to gain insights into the company's financial stability and evaluate its long-term investment potential.

Tatva Chintan Pharma Chem Ltd. - Annual Report

Download the annual reports of Tatva Chintan Pharma Chem Ltd. from our website. The annual report offers detailed information on the company's operations, financial performance, and future prospects. Gain valuable insights into the company's strategies, goals, and achievements, enabling you to assess its growth trajectory and make informed investment decisions.

Tatva Chintan Pharma Chem Ltd. - Dividend

Explore Tatva Chintan Pharma Chem Ltd.'s dividend history on our website. Dividends are a crucial aspect for long-term stock investors seeking stable returns. By analyzing the company's dividend track record, you can evaluate its commitment to distributing profits to its shareholders and make informed decisions regarding dividend-related investment strategies.

Tatva Chintan Pharma Chem Ltd. - Quarterly Result

Stay updated with the latest quarterly results of Tatva Chintan Pharma Chem Ltd. on our website. Monitoring the company's quarterly performance can provide valuable insights into its financial health, growth trajectory, and potential risks. Utilize our pre-built screening tools to conduct in-depth analysis and evaluate the company's strengths and weaknesses.

Tatva Chintan Pharma Chem Ltd. - Stock Price

Monitor the stock price movements of Tatva Chintan Pharma Chem Ltd. on our website. The stock price reflects the market's perception of the company's value and future prospects. Analyzing historical stock price trends can help you identify patterns and make informed decisions regarding buying or selling shares in Tatva Chintan Pharma Chem Ltd.

Tatva Chintan Pharma Chem Ltd. - Price Chart

Visualize and analyze the price chart of Tatva Chintan Pharma Chem Ltd. on our website. By studying the price chart, you can identify trends, patterns, and price levels that can assist in making informed investment decisions. Utilize our pre-built screening tools to perform technical analysis and uncover potential trading opportunities.

Tatva Chintan Pharma Chem Ltd. - News

Stay updated with the latest news about Tatva Chintan Pharma Chem Ltd. on our website. Timely information on company announcements, new product launches, collaborations, and industry developments can significantly impact the stock's price and long-term investment prospects. With our comprehensive news coverage, investors can stay ahead and make informed decisions.

Tatva Chintan Pharma Chem Ltd. - Concall Transcripts

Access the concall transcripts of Tatva Chintan Pharma Chem Ltd. on our website. Concall transcripts provide valuable insights into the company's management discussions, strategic decisions, and outlook for the future. By analyzing these transcripts, investors can gain a deeper understanding of the company's operations and make informed investment decisions.

Tatva Chintan Pharma Chem Ltd. - Investor Presentations

Download the investor presentations of Tatva Chintan Pharma Chem Ltd. from our website. Investor presentations offer detailed information about the company's business model, financial performance, growth strategies, and future prospects. By analyzing these presentations, you can assess the company's potential and make informed investment decisions.

Tatva Chintan Pharma Chem Ltd. - Promoters

Learn about the promoters of Tatva Chintan Pharma Chem Ltd. Promoters play a vital role in shaping a company's vision, strategy, and long-term growth plans. Understanding the background, expertise, and track record of the company's promoters can help investors assess the company's stability, governance, and growth potential.

Tatva Chintan Pharma Chem Ltd. - Shareholders

Stay informed about the major shareholders of Tatva Chintan Pharma Chem Ltd. Shareholder analysis provides insights into the ownership structure of the company and the percentage of shares held by institutional investors, mutual funds, and individual investors. This information can aid in evaluating the company's investor confidence and long-term growth potential.

Remember, on our website, along with the above-mentioned stock analysis, we provide pre-built screening tools, downloadable annual reports, concall transcripts, investor presentations, and premium features such as fair value calculations using DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis. These tools and resources aim to empower long-term stock investors in making sound investment decisions based on comprehensive analysis and research.

Read More
X